Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHAs With and Without Nanocarriers vs Calcipotriol/Betamethasone in Plaque Psoriasis
NCT07816575Completed
- Sponsor
- Al-Azhar University
- Start
- Mar 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, double-blind trial in plaque psoriasis (4 arms), sponsored by Al-Azhar University. Primary endpoint: Psoriasis Area and Severity Index at 8 weeks. Started Mar 2024; status: completed.
02
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07816575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07816575.